Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Feb;18(2):216.
doi: 10.1002/ejhf.452. Epub 2015 Dec 3.

Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?

Affiliations
Comment

Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?

Bertram Pitt et al. Eur J Heart Fail. 2016 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Konstam MA. Hyperkalaemia in heart failure: binding the patient to improved treatment? Eur J Heart Fail 2015;17:997–999. - PubMed
    1. Pitt B, Bakris GL, Bushinsky DA, Garza D, Mayo MR, Stasiv Y, Christ‐Schmidt H, Berman L, Weir MR. Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors. Eur J Heart Fail 2015;17:1057–1065. - PMC - PubMed
    1. Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ‐Schmidt H, Berman L, Pitt B, OPAL‐HK Investigators. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 2015;372:211–221. - PubMed
    1. Pitt B, Collins AJ, Reaven N, Funk S, Bakris GL, Bushinsky DA. Effect of cardiovascular comorbidities on the mortality risk associated with serum potassium. Circulation 2014;130(Suppl 2):A13320.
    1. Einhorn LM, Zhan M, Hsu V, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009;169:1156–1162. - PMC - PubMed